Non-Melanoma Skin Cancers Coverage from Every Angle
Advertisement
Advertisement

Recent News

Case Study: Chemoimmunotherapy Combination in Merkel Cell Carcinoma
Autoimmune Dermatosis in a Pembrolizumab-Treated Patient With Merkel Cell Carcinoma: Case Study
COVID-19, Merkel Cell Carcinoma, and Immunotherapy: Case Study
Hydrochlorothiazide and Non-Melanoma Skin Cancer in Asian Patients
ESMO 2020: Cemiplimab in Cutaneous Squamous Cell Carcinoma: Changes in Pain and Tumor Response
Bone Marrow Involvement From Merkel Cell Carcinoma: Case Study
ESMO 2020: Targeting PD-1 in Merkel Cell Carcinoma
Epidermal Radioisotope Therapy Using Rhenium-188 for Non-Melanoma Skin Cancer
Do Topical Calcineurin Inhibitors Increase the Risk for Skin Cancer?
Finnish Study Shows Benefit of Full-Body Skin Exams in Older Adults
Effects of Immunosuppression in Merkel Cell Carcinoma
Hydrochlorothiazide Drug Label Change to Include Small Risk of Skin Cancer
Invasive Melanoma Arising From Basal Cell Carcinoma Passenger Melanocytes: Case Study
Does Facility Volume Impact Survival Outcomes in Merkel Cell Carcinoma?
Is Hydrochlorothiazide Linked to Increased Risk for Skin Cancer?
Perineural Invasion in Basal Cell Carcinoma
KEYNOTE-629: Pembrolizumab in Metastatic Cutaneous Squamous Cell Carcinoma
Front-Line Immunotherapy for Locally Advanced Basal Cell Carcinoma: Case Studies
Sex-Dependent Distribution of Non-Melanoma Skin Cancers of the Pinna
Sun Health Behaviors and Skin Cancer Risk in Children: Public Health Report From Ireland
Case Study Features Association Between Rare Skin Condition and Basal Cell Carcinoma
Identifying High-Risk Patients With Cutaneous Squamous Cell Carcinoma for Clinical Trial
Health-Related Quality of Life With Cemiplimab for Skin Cancer
Call to Action: Skin Cancer Surveillance in Patients With Organ Transplants
AACR II: Linking HPV Infection to Skin Cancer in Patients With CLL
Immune-Mediated Adverse Events With Concomitant Radiotherapy and Immunotherapy
AACR II: Does Cyclooxygenase-2 Inhibitor Use Reduce the Risk of Skin Cancer?
AACR II: Early Tanning Bed Use and Risk for Skin Cancer
Pembrolizumab Approved by FDA for Cutaneous Squamous Cell Carcinoma
AACR II: Do Permanent Hair Dyes Increase the Risk of Skin Cancer?
ASCO20: Upfront Treatment With Cemiplimab for Locally Advanced Skin Cancer
Preclinical Study of Plant Flavonoid in Treatment of Squamous Cell Skin Cancer
ASCO20: Longer-Term Follow-Up Supports Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
ASCO20: Predicting Subclinical Progression of Squamous Cell Carcinoma
ASCO20: Total-Body Skin Exams and Diagnosis of Skin Cancers
ASCO20: Targeting MDM2 in Merkel Cell Carcinoma
ASCO20: Preserving Eye Function in Locally Advanced Orbital/Periocular Basal Cell Carcinoma
Skin Cancer Awareness Month: Recommendations for Prevention
Managing Patients With Skin Cancer During the COVID-19 Pandemic
Exploring Staph Bacteria’s Connection to Growth of Skin Cancers
DDW 2020: Risk of Skin Cancer in Patients With Inflammatory Bowel Disease
COVID-19 and Skin Cancer: Meeting Clinical Challenges in Dermatology
Non-Melanoma Skin Cancer: A Continual Problem for Outdoor Workers
STAT3 Pathway: Therapeutic Target in Cutaneous Squamous Cell Carcinoma?
Pembrolizumab Receives FDA Accelerated Approval for Alternative Dosing Schedule


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.